scispace - formally typeset
H

Helena Jablonowski

Researcher at Leibniz Association

Publications -  21
Citations -  2004

Helena Jablonowski is an academic researcher from Leibniz Association. The author has contributed to research in topics: Plasma medicine & Radical. The author has an hindex of 13, co-authored 21 publications receiving 1504 citations. Previous affiliations of Helena Jablonowski include Leibniz Institute for Neurobiology.

Papers
More filters
Journal ArticleDOI

Plasma-liquid interactions: A review and roadmap

TL;DR: A review of the state-of-the-art of this multidisciplinary area and identifying the key research challenges is provided in this paper, where the developments in diagnostics, modeling and further extensions of cross section and reaction rate databases are discussed.
Journal ArticleDOI

Research on plasma medicine-relevant plasma–liquid interaction: What happened in the past five years?

TL;DR: Peroxynitrite (ONOO–) was identified to play a crucial role for biological effects of plasma-treated liquids and to open up innovative fields of plasma application in medicine.
Journal ArticleDOI

Potential of pulsed corona discharges generated in water for the degradation of persistent pharmaceutical residues.

TL;DR: A plasma reactor with a coaxial geometry to generate large volume corona discharges directly in water and investigated the degradation of seven recalcitrant pharmaceuticals, finding no acidification and only an insignificant increase in nitrate/nitrite concentrations below legal limits for the treatment.
Journal ArticleDOI

Long-lived and short-lived reactive species produced by a cold atmospheric pressure plasma jet for the inactivation of Pseudomonas aeruginosa and Staphylococcus aureus.

TL;DR: Different chemical pathways leading to the inactivation of Pseudomonas aeruginosa and Staphylococcus aureus by a cold atmospheric pressure plasma jet (APPJ) in buffered and non‐buffered solutions are reported.
Journal ArticleDOI

Oxygen atoms are critical in rendering THP-1 leukaemia cells susceptible to cold physical plasma-induced apoptosis.

TL;DR: A plasma setting that inactivates previously unresponsive leukaemia cells is presented, deciphering the complexity of plasma from the gas phase into the liquid down to the cellular response mechanism and may help tailoring plasmas for clinical applications such as oxidation-insensitive types of cancer.